Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Genomics, |
RCV000236395 | SCV000256855 | pathogenic | Propionic acidemia | 2012-01-01 | criteria provided, single submitter | research | |
Counsyl | RCV000236395 | SCV000800257 | likely pathogenic | Propionic acidemia | 2018-05-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000236395 | SCV000936965 | pathogenic | Propionic acidemia | 2023-10-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg476*) in the PCCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCCA are known to be pathogenic (PMID: 15464417). This variant is present in population databases (rs768703749, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with propionic acidemia (PMID: 27227689, 32252659). ClinVar contains an entry for this variant (Variation ID: 218264). For these reasons, this variant has been classified as Pathogenic. |
Kasturba Medical College, |
RCV000236395 | SCV002053732 | likely pathogenic | Propionic acidemia | criteria provided, single submitter | clinical testing | ||
Revvity Omics, |
RCV000236395 | SCV003824754 | pathogenic | Propionic acidemia | 2022-05-19 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000236395 | SCV002094977 | pathogenic | Propionic acidemia | 2021-01-29 | no assertion criteria provided | clinical testing |